Wissenschaftliche Arbeiten

Doç. Dr. Berkan Armağan

299 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. AB0724 TOFACITINIB DRUG SURVIVAL MAY BE BETTER IN OBESE TNF INHIBITOR RESISTANT RA PATIENTS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.1726 Quelle: OpenAlex

  2. POS0857 REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3977 Quelle: OpenAlex

  3. AB1272 MANAGING OF ANCA-ASSOCIATED VASCULITIS: ADHERENCE TO TREATMENT GUIDELINES AND EARLY MODIFICATIONS, ARE WE THERE YET?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5318 Quelle: OpenAlex

  4. AB0950 DRUG SURVIVAL AND PREDICTOR FACTORS OF DISCONTINUATION IN AXIAL SPONDYLOARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB AND SECUKINUMAB

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3290 Quelle: OpenAlex

  5. Romatolojide Güncel Tedaviler

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2736 Frei zugänglicher VolltextQuelle: OpenAlex

  6. AB1586-HPR REASONS FOR STOPPING HYDROXYCHLOROQUINE: DO WE GIVE UP EASILY?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.4806 Quelle: OpenAlex

  7. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study

    Clinical and Experimental Rheumatology, 2024

    DOI 10.55563/clinexprheumatol/pzbg88 PMID 41031678 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  8. A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024

    DOI 10.55730/1300-0144.5872 PMID 39473762 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  9. Treatment patterns of rheumatoid arthritis across different age groups

    Medicine Science | International Medical Journal, 2024

    DOI 10.5455/medscience.2024.02.016 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. A disease to consider in the differential diagnosis of lower back pain: Celiac disease and related autoimmune disorders

    Ankara City Hospital Medical Journal, 2024

    DOI 10.5505/achmedj.2024.02997 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  11. Frailty assessment in patients with Behçet's syndrome: A cross-sectional monocentric study

    Reumatología Clínica (English Edition), 2024

    DOI 10.1016/j.reumae.2024.09.005 PMID 39396353 1 Zitation (OpenAlex) Quelle: OpenAlex

  12. OP0175 COMORBIDITIES IN 347.902 RHEUMATOID ARTRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3152 1 Zitation (OpenAlex) Quelle: OpenAlex

  13. AB0397 CHARACTERISTICS OF PATIENTS WITH DIFFICULT TO TREAT PSORIATIC ARTHRITIS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3430 1 Zitation (OpenAlex) Quelle: OpenAlex

  14. Impact of the long-term hydroxychloroquine use on COVID-19 severity in patients with autoimmune rheumatic disease

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2024

    DOI 10.31067/acusaglik.1344997 Frei zugänglicher VolltextQuelle: OpenAlex

  15. POS1237 PERIPHERAL NERVOUS SYSTEM INVOLVEMENT OF SJÖGREN DISEASE: CHARACTERIZATION AT THE TIME OF DIAGNOSIS IN 16,703 PATIENTS FROM THE SJÖGREN BIG DATA REGISTRY

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3613 Quelle: OpenAlex

  16. POS1247 CHARACTERIZATION OF 284 PATIENTS PRESENTING WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS OF SJÖGREN DISEASE: RESULTS FROM THE SJÖGREN BIG DATA REGISTRY

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3610 Quelle: OpenAlex

  17. AB0827 OFF-LABEL USE OF BIOLOGICS AND SMALL MOLECULES IN SJÖGREN DISEASE: REAL-WORLD DATA FROM THE INTERNATIONAL SJÖGREN BIG DATA COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3844 Quelle: OpenAlex

  18. AB0641 DEMOGRAPHIC CHARACTERISTICS, COMORBIDITIES AND TREATMENT CHOICES OF EARLY AND LATE ONSET RA PATIENTS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3297 Quelle: OpenAlex

  19. Frailty assessment in patients with Behçet's syndrome: A cross-sectional monocentric study

    Reumatología Clínica, 2024

    DOI 10.1016/j.reuma.2024.04.004 Quelle: OpenAlex

  20. AB0535 ALMOST TWO AND HALF PRECENTAGE OF RA PATIENTS HAD DIFFICULT TO TREAT (D2T): RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3305 Quelle: OpenAlex

  21. AB0394 COMORBIDITIES IN 40.643 PSORIATIC ARTHRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3391 Quelle: OpenAlex

  22. Age-Related Variations in Treatment Patterns for Axial Spondyloarthritis

    Medical Records, 2024

    DOI 10.37990/medr.1481080 Frei zugänglicher VolltextQuelle: OpenAlex

  23. Glucocorticoids in IgA vasculitis

    Acta Medica, 2024

    DOI 10.32552/2024.actamedica.1100 Frei zugänglicher VolltextQuelle: OpenAlex

  24. AB0777 PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5370 Frei zugänglicher VolltextQuelle: OpenAlex

  25. AB0284 EVALUATION OF THE RELATIONSHIP BETWEEN SERUM NETRIN-1 LEVEL AND PATIENT CHARACTERISTICS IN RHEUMATOID ARTHRITIS

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.6270 Frei zugänglicher VolltextQuelle: OpenAlex

  26. AB1059 NETRIN-1 IN SPONDYLOARTHRITIS: A NOVEL MARKER TO PREDICT DISEASE ACTIVITY?

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.6349 Frei zugänglicher VolltextQuelle: OpenAlex

  27. EVALUATION OF THE RELATIONSHIP BETWEEN SERUM NETRIN-1 LEVEL AND PATIENT CHARACTERISTICS IN RHEUMATOID ARTHRITIS

    AYBU AVESIS, 2023

    Quelle: OpenAlex

  28. Rheumatology experience with FDG PET/CT in inflammation of unknown origin: a single-centre report for determining factors associated with diagnostic precision

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06673-x PMID 37338744 6 Zitationen (Europe PMC) Quelle: ORCID

  29. AB1553 INVESTIGATION OF FACTORS ASSOCIATED WITH PET/CT EXPERIENCE AND DIAGNOSTIC VALUE IN RHEUMATOLOGY PRACTICE

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.4011 Frei zugänglicher VolltextQuelle: OpenAlex

  30. Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

    International journal of rheumatic diseases, 2023

    DOI 10.1111/1756-185x.14490 PMID 36371485 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  31. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis

    Laboratory medicine, 2023

    DOI 10.1093/labmed/lmad019 PMID 37100766 5 Zitationen (Europe PMC) Quelle: Europe PMC

  32. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

    Immunopharmacology and immunotoxicology, 2023

    DOI 10.1080/08923973.2022.2160729 PMID 36537308 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  33. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/zr7s0g PMID 37976117 6 Zitationen (OpenAlex) Quelle: OpenAlex

  34. Tofacitinib experience in patients with enteropathic arthritis

    Immunotherapy, 2023

    DOI 10.2217/imt-2022-0110 PMID 37009645 5 Zitationen (OpenAlex) Quelle: OpenAlex

  35. Ustekinumab in Enteropathic Arthritis

    Immunotherapy, 2023

    DOI 10.2217/imt-2022-0197 PMID 37020400 5 Zitationen (OpenAlex) Quelle: OpenAlex

  36. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

    Irish Journal of Medical Science (1971 -), 2023

    DOI 10.1007/s11845-023-03519-y PMID 37737913 4 Zitationen (OpenAlex) Quelle: OpenAlex

  37. COVID ‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14676 PMID 36942871 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  38. Effects of breast milk on Behçet's disease clinical features

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5565 PMID 36945965 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases

    Iranian Journal of Parasitology, 2023

    DOI 10.18502/ijpa.v18i2.13190 PMID 37583642 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

    Vaccines, 2023

    DOI 10.3390/vaccines11071234 PMID 37515050 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  41. AB1691 BURDEN OF AFFECTED FACE IN PATIENTS WITH SYSTEMIC SCLEROSIS: A TRANSLATION AND VALIDATION STUDY IN TURKISH

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5553 Frei zugänglicher VolltextQuelle: OpenAlex

  42. AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3450 Frei zugänglicher VolltextQuelle: OpenAlex

  43. Rituximab use may indicate impaired quality of life in granulomatosis with polyangiitis

    Ulusal Romatoloji Dergisi, 2023

    DOI 10.4274/raed.galenos.2023.59244 Frei zugänglicher VolltextQuelle: OpenAlex

  44. Ulusal dev hücreli arterit veritabanı izlem verisi: Relaps oranı kontrollü çalışmalardan düşüktür.

    Kocaeli Üniversitesi - AVESİS, 2023

    Quelle: OpenAlex

  45. Spondiloartropati hastalarında secukinumab ve sertolizumab tedavilerin karşılaştırılması

    AYBU AVESIS, 2023

    Quelle: OpenAlex

  46. Neurological Involvement in Patients with Primary Sjögren’s Syndrome: A Retrospective Cross-Sectional Study

    Annals of Indian Academy of Neurology, 2023

    DOI 10.4103/aian.aian_138_23 PMID 37970299 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  47. AB0638 NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME: A RETROSPECTIVE CROSS-SECTIONAL STUDY

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3862 Frei zugänglicher VolltextQuelle: OpenAlex

  48. Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study

    EClinicalMedicine, 2023

    DOI 10.1016/j.eclinm.2023.102062 PMID 37457113 34 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  49. Pulmonary hypertension in Behcet?s disease: echocardiographic screening and multidisciplinary approach

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5617 PMID 37476876 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  50. The impact of antiphospholipid antibodies in Takayasu arteritis

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5573 PMID 36945962 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID